Dengue Virus Diagnostic Tests Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product (Vector-based Cas, DNA-free Cas); Application (Genome Engineering, Disease models, Functional Genomics, Knockdown/activation, Others); End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations) Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM rapid Test, Others); End User (Hospitals, Clinics, Diagnostic Centers) and Geography
Report Code: TIPRE00006877 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Dengue is a disease caused to humans by mosquitoes. The most common blood tests used for diagnosing dengue virus are either ELISA based or PCR based. The newly developed rapid point-of-care tests enable the early identification and prompt notification of the disease. The most commonly tests performed are dengue NS1 antigen test and dengue IgM/IgG serological test.
MARKET DYNAMICS
The dengue virus diagnostic tests market is anticipated to grow in the forecast, owing increasing cases of of dengue fever, increasing government initiatives for dengue detection and treatment and growing awareness among the population. In addition, increasing research for early detection of dengue is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Dengue Virus Diagnostic Tests Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of dengue virus diagnostic tests market with detailed market segmentation by test type, and end user and geography. The dengue virus diagnostic tests market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading dengue virus diagnostic tests market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The dengue virus diagnostic tests market is segmented on the basis of test type and end user. Based on test type the market is segmented as ELISA-based tests, RT-PCR based tests, dengue IgG/IgM rapid Test, and others. The end user segment is classified into hospitals, clinics, diagnostic centers.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the dengue virus diagnostic tests market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dengue virus diagnostic tests market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting dengue virus diagnostic tests market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the dengue virus diagnostic tests market in these regions.
The report covers key developments in the dengue virus diagnostic tests market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Dengue virus diagnostic tests market are anticipated to have lucrative growth opportunities in the future with the rising demand for dengue virus diagnostic tests market in the global market. Below mentioned is the list of few companies engaged in the dengue virus diagnostic tests market.
The report also includes the profiles of key dengue virus diagnostic tests market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Dengue is a disease caused to humans by mosquitoes. The most common blood tests used for diagnosing dengue virus are either ELISA based or PCR based. The newly developed rapid point-of-care tests enable the early identification and prompt notification of the disease. The most commonly tests performed are dengue NS1 antigen test and dengue IgM/IgG serological test.
MARKET DYNAMICS
The dengue virus diagnostic tests market is anticipated to grow in the forecast, owing increasing cases of of dengue fever, increasing government initiatives for dengue detection and treatment and growing awareness among the population. In addition, increasing research for early detection of dengue is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Dengue Virus Diagnostic Tests Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of dengue virus diagnostic tests market with detailed market segmentation by test type, and end user and geography. The dengue virus diagnostic tests market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading dengue virus diagnostic tests market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The dengue virus diagnostic tests market is segmented on the basis of test type and end user. Based on test type the market is segmented as ELISA-based tests, RT-PCR based tests, dengue IgG/IgM rapid Test, and others. The end user segment is classified into hospitals, clinics, diagnostic centers.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the dengue virus diagnostic tests market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dengue virus diagnostic tests market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting dengue virus diagnostic tests market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the dengue virus diagnostic tests market in these regions.
The report covers key developments in the dengue virus diagnostic tests market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Dengue virus diagnostic tests market are anticipated to have lucrative growth opportunities in the future with the rising demand for dengue virus diagnostic tests market in the global market. Below mentioned is the list of few companies engaged in the dengue virus diagnostic tests market.
The report also includes the profiles of key dengue virus diagnostic tests market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Arkray Inc.
- Ceres Nanosciences Inc
- Abbott,
- Quest Diagnostics
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Quidel Corp
- Whidiag SAS
- Pictor Ltd